Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 2 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Boundless Bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 55 | +9 |
| Shares | 13.8M | 517.1K | 13.3M | −49.3K (−0.4%) |
| Value | $53.4M | $2.00M | $46.1M | −$5.37M (−10.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Boundless Bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 408,686 | $1.42M | 0.00% |
| Northern Trust Corp | 57,578 | $199.8K | 0.00% |
| UBS Oconnor LLC | 53,168 | $184.5K | 0.00% |
| Bridgeway Capital Management, LLC | 50,000 | $173.5K | 0.00% |
| Goldman Sachs Group Inc | 11,356 | $39.4K | 0.00% |
| Prelude Capital Management, LLC | 11,024 | $38.3K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,681 | $12.8K | 0.00% |
| Legal & General Group Plc | 1,049 | $3.63K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 826 | $2.87K | 0.00% |
| Russell Investments Group, Ltd. | 49 | $170 | 0.00% |
| Capital Performance Advisors LLP | 42 | $146 | 0.00% |
| Sterling Capital Management LLC | 12 | $42 | 0.00% |
| CWM, LLC | 132 | $0 | 0.00% |
Sold out (4)
Institutions that held Boundless Bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Millennium Management LLC | 234,663 | $908.1K |
| Altium Capital Management LP | 83,149 | $321.8K |
| Sandia Investment Management LP | 7,500 | $29.0K |
| Cubist Systematic Strategies, LLC | 520 | $2.01K |
Not filed for Q3 2024 yet (1)
Institutions that held Boundless Bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 517,094 | $2.00M |